Clinical Trial

A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Benign Prostatic Hyperplasia (BPH) is a common condition that can cause bothersome urination problems and reduce quality of life. Accurately measuring how the bladder empties is important for diagnosis and treatment, but current methods like uroflowmetry can be inconvenient and are done only at a clinic. This study aims to test a new, non-invasive smart wearable device that uses Electrical Impedance Tomography (EIT) to monitor bladder function in patients with BPH. The device is worn on the lower abdomen. In this study, participants will use this EIT device while also undergoing the standard uroflowmetry test. The main goal is to see how well the measurements from the new device (like urine flow rate and volume) agree with those from the standard test. The study hopes to show that this wearable device can accurately and comfortably track bladder function over time. If successful, it could lead to a new tool for doctors to better monitor patients with BPH, even potentially at home.
Trial Details
NCT Number NCT07357012
Lead Sponsor Peking University Third Hospital
Conditions Benign Prostatic Hyperplasia
Enrollment 40 participants
Start Date 2026-01-15
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21